Outlook Therapeutics Inc. (OTLK)
OTLK trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.5638
-3.64% on the day
Market cap
$137.3M
Micro cap
Revenue · 2025
$1.4M
No prior year to compare
Net income · 2025
-$62.4M
-4416.2% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | OTLK on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | 2016 |
| SEC CIK | 0001649989 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $1.4M |
| Net income | -$62.4M |
| Operating income | -$67.1M |
| Net margin | -4416.2% |
| Operating margin | -4744.3% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $8.7M |
| Total assets | $18.2M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 97.1× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-08-14 |
| Latest annual report | 10-K | 2025-12-19 |
| Latest quarterly / interim | 10-Q | 2026-08-18 |
| Latest current report FORM 8-K | 8-K | 2026-09-30 |
| Latest proxy | DEFA14A | 2026-07-10 |
Source: SEC EDGAR submissions feed, 833 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| AVXL | Anavex Life Sciences Corp. | $1.48 | -1.99% | $137.2M |
| MOLN | Molecular Partners AG | $3.67 | -3.17% | $137.7M |
| VYGR | Voyager Therapeutics Inc. | $2.15 | -5.29% | $132.5M |
| ABOS | Acumen Pharmaceuticals Inc. | $1.81 | -10.15% | $131.3M |
| CRDL | Cardiol Therapeutics Inc. Class A Common Shares | $1.20 | +1.70% | $144.8M |
| CMPX | Compass Therapeutics Inc. | $0.8570 | -8.59% | $154.3M |
| TARA | Protara Therapeutics Inc. | $2.62 | -5.42% | $154.8M |
| TNYA | Tenaya Therapeutics Inc. | $0.5210 | -7.87% | $116.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier